Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 1
2008 2
2009 3
2010 2
2011 3
2012 3
2013 1
2014 6
2015 6
2016 8
2017 3
2018 5
2019 6
2020 6
2021 10
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Single-Cell Survey of Human Lymphatics Unveils Marked Endothelial Cell Heterogeneity and Mechanisms of Homing for Neutrophils.
Takeda A, Hollmén M, Dermadi D, Pan J, Brulois KF, Kaukonen R, Lönnberg T, Boström P, Koskivuo I, Irjala H, Miyasaka M, Salmi M, Butcher EC, Jalkanen S. Takeda A, et al. Among authors: hollmen m. Immunity. 2019 Sep 17;51(3):561-572.e5. doi: 10.1016/j.immuni.2019.06.027. Epub 2019 Aug 8. Immunity. 2019. PMID: 31402260 Free article.
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.
Virtakoivu R, Rannikko JH, Viitala M, Vaura F, Takeda A, Lönnberg T, Koivunen J, Jaakkola P, Pasanen A, Shetty S, de Jonge MJA, Robbrecht D, Ma YT, Skyttä T, Minchom A, Jalkanen S, Karvonen MK, Mandelin J, Bono P, Hollmén M. Virtakoivu R, et al. Among authors: hollmen m. Clin Cancer Res. 2021 Aug 1;27(15):4205-4220. doi: 10.1158/1078-0432.CCR-20-4862. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078651 Clinical Trial.
NGAL-Siderocalin in kidney disease.
Paragas N, Qiu A, Hollmen M, Nickolas TL, Devarajan P, Barasch J. Paragas N, et al. Among authors: hollmen m. Biochim Biophys Acta. 2012 Sep;1823(9):1451-8. doi: 10.1016/j.bbamcr.2012.06.014. Epub 2012 Jun 19. Biochim Biophys Acta. 2012. PMID: 22728330 Free PMC article. Review.
Editorial: Targeting Myeloid Cells to Fight Cancer.
Hollmén M, Zheng W, Pollard JW. Hollmén M, et al. Front Immunol. 2019 Dec 3;10:2835. doi: 10.3389/fimmu.2019.02835. eCollection 2019. Front Immunol. 2019. PMID: 31849994 Free PMC article. No abstract available.
Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice.
Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M. Dunkel J, et al. Among authors: hollmen m. Front Immunol. 2018 Oct 8;9:2257. doi: 10.3389/fimmu.2018.02257. eCollection 2018. Front Immunol. 2018. PMID: 30349531 Free PMC article.
Clever-1 positive macrophages in breast cancer.
Mutka M, Virtakoivu R, Joensuu K, Hollmén M, Heikkilä P. Mutka M, et al. Among authors: hollmen m. Breast Cancer Res Treat. 2022 Oct;195(3):237-248. doi: 10.1007/s10549-022-06683-4. Epub 2022 Aug 2. Breast Cancer Res Treat. 2022. PMID: 35917053 Free PMC article.
64 results